1-3 of 3
Neill Giese
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia

Julia Hoellenriegel, Sarah A. Meadows, Mariela Sivina, William G. Wierda, Hagop Kantarjian, Michael J. Keating, Neill Giese, Susan O'Brien, Albert Yu, Langdon L. Miller, Brian J. Lannutti, Jan A. Burger
Journal: Blood
Blood (2011) 118 (13): 3603–3612.
https://doi.org/10.1182/blood-2011-05-352492
Published: 2011
Includes: Supplemental data
Journal Articles

Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD

Jennifer L. Rocnik, Rachel Okabe, Jin-Chen Yu, Benjamin H. Lee, Neill Giese, David P. Schenkein, D. Gary Gilliland
Journal: Blood
Blood (2006) 108 (4): 1339–1345.
https://doi.org/10.1182/blood-2005-11-011429
Published: 2006
Includes: Supplemental data
Journal Articles

Effects of MLN518, a dual FLT3 and KIT inhibitor, on normal and malignant hematopoiesis

Ian J. Griswold, Lei J. Shen, Paul La Rosée, Shadmehr Demehri, Michael C. Heinrich, Rita M. Braziel, Laura McGreevey, Andrea D. Haley, Neill Giese, Brian J. Druker, Michael W.N. Deininger
Journal: Blood
Blood (2004) 104 (9): 2912–2918.
https://doi.org/10.1182/blood-2003-05-1669
Published: 2004